понедельник, 13 февраля 2017 г.

Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq

Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq


Saunder-led Allergan is buying body-sculptor Zeltiq. Saunder deems it to be the Botox of 10 years ago; expects the deal to be immediately accretive.



from Biotech News